专题：Vascular Tumors and Angiosarcomas

This cluster of papers focuses on the research and clinical aspects of vascular tumors, particularly angiosarcoma and epithelioid hemangioendothelioma. It covers topics such as treatment outcomes, diagnostic markers, genetic alterations, risk factors, and therapeutic options for various types of vascular tumors. The cluster also explores the impact of radiation therapy on the development of angiosarcoma and the role of liver transplantation in managing hepatic angiosarcoma.
最新文献
Scrotal angiokeratoma successfully treated with Nd: YAG laser

article Full Text OpenAlex

Експресія білка щільних з’єднань ZO-1 у карциномах щитоподібної залози

article Full Text OpenAlex

Practice updates: Emerging entities in bone and soft tissue pathology

review Full Text OpenAlex

The VASCERN-VASCA diagnostic and management pathways for kaposiform hemangioendothelioma

article Full Text OpenAlex

Recent developments in eosinophilic renal neoplasms: what's new, true and important?

review Full Text OpenAlex

Thyroid angiosarcoma: a comprehensive review

review Full Text OpenAlex

Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study

article Full Text OpenAlex

Younger age is associated with favorable outcomes in adult dogs with hemangiosarcoma receiving adjuvant doxorubicin chemotherapy: results from the PRO-DOX study

article Full Text OpenAlex

Immunohistochemical and Molecular Testing for the Diagnosis of Primary Cutaneous Ewing Sarcoma: A Comprehensive Review

article Full Text OpenAlex

Long-Term Remission of Peritoneal Lymphangiomatosis with Sirolimus Therapy: A Case Report with 8-Year Follow-Up

article Full Text OpenAlex

近5年高被引文献
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1117 FWCI50.9164

ISSVA Classification of Vascular Anomalies and Molecular Biology

review Full Text OpenAlex 261 FWCI53.4075

Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

review Full Text OpenAlex 208 FWCI19.0837

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

article Full Text OpenAlex 152 FWCI20.9819

Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives

review Full Text OpenAlex 146 FWCI125.1601

Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma

article Full Text OpenAlex 126 FWCI17.9319

Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy

review Full Text OpenAlex 124 FWCI10.4992

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

article Full Text OpenAlex 117 FWCI51.106

Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial

article Full Text OpenAlex 112 FWCI16.1152

mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion

article Full Text OpenAlex 104 FWCI24.2947